Note 10 - Stock-Based Compensation - Summary of Stock Options (Details) |
3 Months Ended |
|---|---|
|
Mar. 31, 2026
USD ($)
$ / shares
shares
| |
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |
| Outstanding (in shares) | 417,048 |
| Equity Plans [Member] | |
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |
| Outstanding (in shares) | 0 |
| Outstanding, weighted average exercise price (in dollars per share) | $ / shares | $ 0 |
| Granted (in shares) | 417,048 |
| Granted, weighted average exercise price (in dollars per share) | $ / shares | $ 14.68 |
| Outstanding (in shares) | 417,048 |
| Outstanding, weighted average exercise price (in dollars per share) | $ / shares | $ 14.68 |
| Aggregate intrinsic value, outstanding | $ | $ 6,122,265 |
| Exercisable, end of the period (in shares) | 417,048 |
| Available for grant, end of period (in shares) | 2,816,539 |
| Weighted average fair value of options granted during the period (in dollars per share) | $ / shares | $ 6.18 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|